Regeneron Pharma (REGN) PT Raised to $800 at Baird
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Regeneron (REGN) gets 2nd upgrade in two days as Jefferies moves to Buy
March 24, 2023 8:33 AM EDTJefferies analyst Akash Tewari raised his recommendation on Regeneron (NASDAQ: REGN) to Buy from Hold and hiked the price target by $250 to $925 per share after the company hit two home runs within a short period of time.
Regeneron shares soared yesterday after the... More
